Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 19 phantom stock units through the Pfizer Supplemental Savings Plan on March 28, 2024.

Summary

• On March 28, 2024, Albert Bourla, Chairman and CEO of Pfizer Inc., acquired 19 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The acquisition was reported on a Form 4 filing with the SEC on April 1, 2024.
• Following the transaction, Bourla directly owns 659,207 shares of Pfizer common stock.
• The phantom stock units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't inherently indicate positive or negative outlook.

Positives

• The acquisition of phantom stock units by the CEO could be interpreted as a sign of confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings in the company's stock.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves phantom stock units and not direct stock purchases on the open market.

Key Dates